Document is current
Any future updates will be listed below
-
Authors
Truong, Dong-Jiunn Jeffery https://orcid.org/0000-0003-1722-8573
Phlairaharn, Teeradon https://orcid.org/0000-0001-6031-0578
Eßwein, Bianca
Gruber, Christoph
Tümen, Deniz
Baligács, Enikő
Armbrust, Niklas
Vaccaro, Francesco Leandro
Lederer, Eva-Maria https://orcid.org/0000-0002-1220-1040
Beck, Eva Magdalena
Geilenkeuser, Julian
Göppert, Simone
Krumwiede, Luisa
Grätz, Christian
Raffl, Gerald https://orcid.org/0000-0003-0210-0286
Schwarz, Dominic
Zirngibl, Martin https://orcid.org/0000-0003-4485-8423
Živanić, Milica
Beyer, Maren
Körner, Johann Dietmar
Santl, Tobias
Evsyukov, Valentin
Strauß, Tabea
Schwarz, Sigrid C.
Höglinger, Günter U. https://orcid.org/0000-0001-7587-6187
Heutink, Peter
Doll, Sebastian
Conrad, Marcus https://orcid.org/0000-0003-1140-5612
Giesert, Florian https://orcid.org/0000-0001-6825-8858
Wurst, Wolfgang
Westmeyer, Gil Gregor https://orcid.org/0000-0001-7224-8919
- License Information
-
More Information
Article History
Received: 6 January 2020
Accepted: 1 April 2021
First Online: 3 June 2021
Competing interests
: D.-J.J.T., G.G.W. and W.W. have filed a patent (WO2020161236) disclosing the capabilities of EXSISERS. M.C. is co-founder and shareholder of ROSCUE Therapeutics GmbH. The other authors declare no competing interests.
